Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Introduction Current guidelines for the management of puberty in trans-masculine (TM) youth (those who identify on the masculine spectrum of gender and were assigned female sex at birth) include offering patients gonadotropin-releasing hormone agonists (GnRHa) at the beginning of puberty.1 These are recommended for the primary purpose of decreasing unwanted secondary sexual characteristics.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
